Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Acta Derm Venereol ; 104: adv38889, 2024 Jun 19.
Article in English | MEDLINE | ID: mdl-38898676

ABSTRACT

A Swedish translation of the patient-reported outcome measure for assessing long-term control of atopic dermatitis, Recap of atopic eczema (RECAP), has not been validated. Cross-cultural translation and multi-centre validation of the translated RECAP questionnaire were therefore performed. Disease severity was assessed using the validated Investigator Global Assessment Scale for atopic dermatitis (vIGA-ADTM). The Swedish RECAP was completed by 208 individuals aged 16 years or older with a median age of 36 years (interquartile range [IQR] 27-48). The participants considered the questionnaire suitable for assessing eczema control. The median RECAP score (range 0-28) was 12 (IQR 5-19). The mean and median vIGA-ADTM scores (range 0-4) were 2 (standard deviation [SD] 2) and 3 (IQR 2-4), respectively. A correlation between RECAP and the vIGA-ADTM was observed (p < 0.001). There was no significant change in scores for participants who answered the questionnaire twice within 14 days. Over time, improved or worsened eczema, as evaluat-ed by vIGA-ADTM, affected RECAP scores significantly (p < 0.001). The study suggests that RECAP can assess AD control in a Swedish clinical setting and shows -acceptable reliability.


Subject(s)
Dermatitis, Atopic , Patient Reported Outcome Measures , Severity of Illness Index , Humans , Dermatitis, Atopic/diagnosis , Adult , Female , Sweden , Male , Middle Aged , Reproducibility of Results , Young Adult , Adolescent , Predictive Value of Tests , Cultural Characteristics , Translating , Surveys and Questionnaires , Time Factors , Cross-Cultural Comparison
2.
J Eur Acad Dermatol Venereol ; 38(2): 354-364, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37824103

ABSTRACT

BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease that is associated with allergic comorbidities. However, studies examining comorbidities in childhood AD are incomplete, which may contribute to suboptimal care. OBJECTIVE: The objective was to compare the risk of developing different allergic and non-allergic comorbidities among children with AD to that of a matched non-AD reference cohort in Sweden. METHODS: This was a nationwide population-based cohort study using longitudinal data from primary and specialist care registers. Patients with AD were identified by confirmed diagnosis in primary or specialist care. The non-AD reference cohort was randomly drawn from the general population and matched 1:1 with the AD patients. The risk of developing the following conditions was evaluated: hypersensitivity and allergic disorders, neurological disorders, psychiatric disorders, infections, immunological and inflammatory disorders, Type 1 diabetes (T1D), endocrine and metabolic disorders, skeletal disorders, ocular disorders and malignancies. RESULTS: This study included 165,145 patients with AD (mild-to-moderate [n = 126,681] and severe [n = 38,464]) and an equally sized reference cohort. Patients with AD displayed a higher risk of developing comorbid conditions for all investigated categories, except for T1D and skeletal disorders, compared with the reference cohort. The highest risk compared with the reference cohort was observed for hypersensitivity and allergic disorders (hazard ratio [HR]: 3.87), followed by malignancies (HR: 2.53) and immunological and inflammatory disorders (HR: 2.36). Patients with AD also had higher risk of developing multiple comorbidities (≥2). The risk of comorbidity onset increased alongside AD severity and patients with active AD were associated with increased risk of comorbidity onset compared with patients in remission. CONCLUSIONS: The clinical burden of AD is substantial for children with AD and patients are at an increased risk of developing several comorbid conditions extending beyond the atopic march. Our results also showed a positive association between worsening severity of AD and an increased risk of comorbidity onset.


Subject(s)
Dermatitis, Atopic , Diabetes Mellitus, Type 1 , Neoplasms , Child , Humans , Dermatitis, Atopic/complications , Cohort Studies , Diabetes Mellitus, Type 1/epidemiology , Comorbidity , Neoplasms/complications
3.
Acta Derm Venereol ; 102: adv00718, 2022 May 19.
Article in English | MEDLINE | ID: mdl-35393628

ABSTRACT

Itch is a common symptom, but there is limited evidence on the prevalence of itch in children. The aim of this study was to assess the prevalence of itch in schoolchildren. A questionnaire was developed by experts in the field and based on a literature search. The questionnaire was applied in a pilot study of 25 consecutively selected paediatric patients and their parents. It confirmed the high content validity of the questionnaire, and the questionnaire was comparable to hospital records regarding chronic itch (n = 19, mean consistency 89.47%). The questionnaire was distributed among German schoolchildren in 9/12 randomly selected primary schools in Kiel, Germany. Of 1,722 invited students, 443 schoolchildren aged 6-10 years participated, and 26.2% (n = 116) reported itch. The prevalence of acute itch was 20.0% (n = 87), and 14.7% (n = 65) reported chronic itch. Reduced sleep and mood were often related to chronic itch. This study demonstrated that itch is a common symptom in German schoolchildren.


Subject(s)
Pruritus , Child , Germany/epidemiology , Humans , Pilot Projects , Prevalence , Pruritus/diagnosis , Pruritus/epidemiology , Surveys and Questionnaires
6.
Acta Derm Venereol ; 99(11): 964-970, 2019 Oct 01.
Article in English | MEDLINE | ID: mdl-31289842

ABSTRACT

The burden of atopic dermatitis (AD) was assessed. A population-based, cross-sectional questionnaire study was performed among 34,313 Swedish adults in 2017. The prevalence of AD was 14%. Adults with mild AD had an increased relative risk ratio (RRR) of severe depression (aRRR 1.78, 95% confidence interval (95% CI) 1.50-2.12) and anxiety (aRRR 1.97, 95% CI 1.69-2.30), which was higher for severe AD (aRRR 6.22 95% CI 4.60- 8.42, aRRR 5.62 95% CI 4.10-7.71, respectively). Persons with severe AD were less likely to have a university degree (aRRR 0.55, 95% CI 0.34-0.90) and more likely to have a lower annual income (238,000-324,000 SEK: aRRR 0.51, 95% CI 0.39-0.77; 325,000 SEK or more 0.36; 0.25-0.58) compared with individuals without AD. These results suggest that AD implies an increased prevalence of comorbid mental conditions and an adverse impact on academic achievement and work. These adverse associations increase substantially for patients with severe AD and comorbid asthma.


Subject(s)
Cost of Illness , Dermatitis, Atopic/epidemiology , Adolescent , Adult , Aged , Anxiety/epidemiology , Anxiety/psychology , Comorbidity , Cross-Sectional Studies , Depression/epidemiology , Depression/psychology , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/psychology , Educational Status , Female , Health Surveys , Humans , Income , Male , Mental Health , Middle Aged , Prevalence , Risk Factors , Severity of Illness Index , Social Determinants of Health , Sweden/epidemiology , Young Adult
7.
Pediatr Dermatol ; 36(4): 501-504, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30907017

ABSTRACT

Terra firma-forme dermatosis (TFFD), first described by Duncan in 1987, is a relatively common but probably underdiagnosed condition, characterized by a reticular hyperpigmented dirtlike eruption resistant to washing with common soap but typically removed with rubbing with 70% isopropyl alcohol. We present a case of TFFD in an 8-year-old boy with rapid response to 5% salicylic acid in petrolatum ointment.


Subject(s)
Dermoscopy/methods , Exanthema/diagnosis , Hyperpigmentation/diagnosis , Hyperpigmentation/drug therapy , Salicylic Acid/therapeutic use , Skin Diseases, Eczematous/diagnosis , Administration, Topical , Child , Diagnosis, Differential , Female , Humans , Severity of Illness Index , Treatment Outcome
9.
Case Rep Dermatol Med ; 2018: 1036162, 2018.
Article in English | MEDLINE | ID: mdl-30538869

ABSTRACT

We report a case report of lupus vulgaris (LV) presented on the extremities of an 80-year-old man. He was misdiagnosed as having psoriasis and referred to our department for a second-opinion evaluation. The discrepancy between the clinical manifestation which was misleading and the dermatoscopic findings raised the suspicion of an underlying granulomatous disease and we proceeded to skin biopsy. The histopathologic examination set the diagnosis of LV.

13.
Article in English | MEDLINE | ID: mdl-28408849

ABSTRACT

BACKGROUND: The incidence of skin diseases in children is influenced by hereditary, social, and environmental factors. The objective of this study was to determine the incidence of pediatric dermatoses at a University Hospital in Northern Greece. PATIENTS AND METHODS: We reviewed epidemiologic data of 940 patients, aged 0-18 years, who were referred to the outpatient clinic of a University Hospital between January 2013 and December 2015. Demographic data and the frequency of the various diagnoses in various age groups were studied. RESULTS: Nine hundred and forty children and adolescents with 1020 diagnoses were included in the study (52.8% females and 47.2% males). The 10 most frequent diagnoses were: dermatitis/eczema (31.5%), viral infections (12.5%), pigmentary disorders (7.4%), melanocytic nevi (5.8%), alopecia areata (5.8%), acne (5.6%), nail disorders (3.3%), vascular malformations and hemangiomas (2.9%), psoriasis (2.6%), and bacterial infections (2.6%). Atopic dermatitis was the most prevalent dermatosis in all age groups accounting for a total of 20.9% of the study population. A remarkably high incidence of various forms of mastocytosis (2.2%) was seen in our data. CONCLUSION: Atopic dermatitis is the most frequent pediatric dermatosis in all age groups. Viral infections, pigmentary disorders, and nevi account for a significant proportion of the referrals. The high incidence of mastocytosis in our study may be attributed to overdiagnosis, overestimation due to the relatively small study population, or it may represent the real incidence of mastocytosis in our region. The low incidence of acne in our study may be attributed to the fact that only severe cases are referred to our hospital.

17.
Dermatol Ther ; 29(5): 338-340, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27357021

ABSTRACT

Hypertrophic lichen planus (HLP) is a variant of lichen planus characterized by marked epidermal hyperplasia and severe pruritus. We present a case of a female patient with HLP and concomitant primary biliary cirrhosis, which responded to topical therapy with betamethasone under occlusion and TCA-peelings.


Subject(s)
Betamethasone/administration & dosage , Chemexfoliation/methods , Glucocorticoids/administration & dosage , Keratolytic Agents/administration & dosage , Lichen Planus/therapy , Occlusive Dressings , Skin/drug effects , Trichloroacetic Acid/administration & dosage , Administration, Cutaneous , Combined Modality Therapy , Female , Humans , Hypertrophy , Lichen Planus/diagnosis , Middle Aged , Skin/pathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...